Clinical Nutrition for Diabetes Care Market Introduction and Overview
According to SPER Market Research, the Global Clinical Nutrition for Diabetes Care Market is estimated to reach USD 3.69 billion by 2034 with a CAGR of 5.04%.
The report includes an in-depth analysis of the Global Clinical Nutrition for Diabetes Care Market, including market size and trends, Interface mix, Applications, and supplier analysis. Clinical nutrition for diabetes care plays a vital role in managing blood glucose levels, preventing complications, and improving overall quality of life for individuals with diabetes. The market for diabetes-focused clinical nutrition is driven by the rising prevalence of diabetes globally, fueled by unhealthy dietary habits, sedentary lifestyles, and aging populations. Advancements in medical nutrition therapy, personalized nutrition solutions, and increasing awareness about the importance of glycemic control have further boosted demand. However, challenges such as high product costs, limited accessibility in low-income regions, and lack of awareness about specialized nutrition products persist. Additionally, regulatory hurdles and varying reimbursement policies create barriers to widespread adoption, despite the growing recognition of clinical nutritions critical role in diabetes care.
By Product Insights: Based on Product the market is divided into three segments: Oral Nutrition, Parenteral Nutrition and Enteral Feeding Formulas. In 2024, oral clinical nutrition dominated the market for diabetes care. Because it greatly helps control blood sugar levels, supports weight regulation, and helps prevent complications associated to diabetes, oral nutritional therapy is essential for managing diabetes. When incorporated into a comprehensive strategy to diabetes management, there is strong evidence that oral nutrition therapy is both cost-effective and effective.
By Stage Insights: Based on Stage the market is divided into two segments: Adult and Pediatric. Adults dominated the diabetic clinical nutrition market in 2024 owing to the growing prevalence of nutritional deficiencies and malnutrition among adults. Adult women over 30 are more likely to experience apathy, weakened muscles, vitamin and calcium deficiencies, lowered immunity, high blood pressure, and exhaustion. Adults suffer from nutritional deficiencies as a result of this.
By Sales Channel Insights: Based on Sales Channel the market is divided into three segments: Online, Retail and Institutional Sales. In 2024, the market was led by the institutional sales sector. Commercial sales to government agencies, medical facilities, and research institutes are included in the sales channel. The segment is driven by an increase in patient visits to hospitals as a result of improved hospital services and the increased prevalence of diseases. Furthermore, there has been an increase in the tendency to seek diabetes care nutrition prescriptions through formal hospital channels as patient knowledge has grown.
By Regional Insights: In 2024, North America dominated the market share for clinical nutrition for diabetes care. Strong healthcare infrastructure, advantageous reimbursement rules, and the existence of sizable clinical nutrition enterprises are the main drivers of the region's high market share. Furthermore, the region's industry has grown because to significant governmental and private investment in healthcare as well as a move toward holistic treatment plans.
Market Competitive Landscape:
The market for Clinical Nutrition for Diabetes Care is quite competitive. In order to increase the range of services and products they offer, companies in the diabetes clinical nutrition market are working with regional players and going worldwide. Some of the prominent players in Global Clinical Nutrition for Diabetes Care Market are Abbott Nutrition, Baxter International Inc, Bayer AG, Danone Nutricia, GlaxoSmithKline plc, Mead Johnson & Company LLC, Nestlé Health Science S.A, Otsuka Holdings Co. Ltd, Pfizer Inc and Victus Inc.
Recent Developments:
- In June 2023, Fresenius Kabi declared the release of the Vasopressin Injection, USP, a generic version of its Vasostrict that treats vasodilatory shock in adults. The business claims that after stopping vasopressin medication, individuals may develop reversible diabetic insipidus.
- In December 2021, Danone India has launched Protinex Diabetes Care, which addresses the dietary requirements of diabetics in India. This product is scientifically designed to supply adequate levels of fiber and protein, which are crucial for controlling blood sugar levels.
- In December 2021, Nestle Health Science started its first prediabetes program in Malaysia, which included a new food supplement that can be added to meals as part of a balanced diet to assist keep blood glucose levels within normal ranges after meals.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Stage, By Sales Channel. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Abbott Nutrition, Baxter International Inc, Bayer AG, Danone Nutricia, GlaxoSmithKline plc, Mead Johnson & Company LLC, Nestle Health Science S.A, Otsuka Holdings Co. Ltd, Pfizer Inc, Victus Inc. and others. |
Key Topics Covered in the Report:
- Global Clinical Nutrition for Diabetes Care Market Size (FY’2021-FY’2034)
- Overview of Global Clinical Nutrition for Diabetes Care Market
- Segmentation of Global Clinical Nutrition for Diabetes Care Market By Product (Oral Nutrition, Parenteral Nutrition and Enteral Feeding Formulas)
- Segmentation of Global Clinical Nutrition for Diabetes Care Market By Stage (Adult and Pediatric)
- Segmentation of Global Clinical Nutrition for Diabetes Care Market By Sales Channel (Online, Retail and Institutional Sales)
- Statistical Snap of Global Clinical Nutrition for Diabetes Care Market
- Expansion Analysis of Global Clinical Nutrition for Diabetes Care Market
- Problems and Obstacles in Global Clinical Nutrition for Diabetes Care Market
- Competitive Landscape in the Global Clinical Nutrition for Diabetes Care Market
- Details on Current Investment in Global Clinical Nutrition for Diabetes Care Market
- Competitive Analysis of Global Clinical Nutrition for Diabetes Care Market
- Prominent Players in the Global Clinical Nutrition for Diabetes Care Market
- SWOT Analysis of Global Clinical Nutrition for Diabetes Care Market
- Global Clinical Nutrition for Diabetes Care Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Clinical Nutrition for Diabetes Care Market Manufacturing Base Distribution, Sales Area, Interface Type
6.2. Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Clinical Nutrition for Diabetes Care Market
7. Global Clinical Nutrition for Diabetes Care Market, By Product (USD Million) 2021-2034
7.1. Oral Nutrition
7.2. Parenteral Nutrition
7.3. Enteral Feeding Formulas
8. Global Clinical Nutrition for Diabetes Care Market, By Stage (USD Million) 2021-2034
8.1. Adult
8.2. Pediatric
9. Global Clinical Nutrition for Diabetes Care Market, By Sales Channel (USD Million) 2021-2034
9.1. Online
9.2. Retail
9.3. Institutional Sales
10. Global Clinical Nutrition for Diabetes Care Market, (USD Million) 2021-2034
10.1. Global Clinical Nutrition for Diabetes Care Market Size and Market Share
11. Global Clinical Nutrition for Diabetes Care Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Abbott Nutrition
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Interface summary
12.1.4. Recent developments
12.2. Baxter International Inc
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Interface summary
12.2.4. Recent developments
12.3. Bayer AG
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Interface summary
12.3.4. Recent developments
12.4. Danone Nutricia
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Interface summary
12.4.4. Recent developments
12.5. GlaxoSmithKline plc
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Interface summary
12.5.4. Recent developments
12.6. Mead Johnson & Company LLC
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Interface summary
12.6.4. Recent developments
12.7. Nestle Health Science S.A
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Interface summary
12.7.4. Recent developments
12.8. Otsuka Holdings Co. Ltd
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Interface summary
12.8.4. Recent developments
12.9. Pfizer Inc
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Interface summary
12.9.4. Recent developments
12.10. Victus Inc
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Interface summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
